These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19226468)

  • 1. Dynamics of central and peripheral immunomodulation in a murine glioma model.
    Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN
    BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
    Jian L; Hu Y; Gao M; Shu L
    Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS
    Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
    Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunosuppressive microenvironment of malignant gliomas].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment.
    Cantini G; Pisati F; Mastropietro A; Frattini V; Iwakura Y; Finocchiaro G; Pellegatta S
    Cancer Immunol Immunother; 2011 Dec; 60(12):1739-50. PubMed ID: 21779877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG; Lysaght J; Todryk S; Mills KH
    J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
    Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
    Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of myeloid-derived suppressor cells and T regulatory cells in lung microenvironment after Urethane-induced lung tumor.
    Rosin FC; Pedregosa JF; de Almeida JS; Bueno V
    Int Immunopharmacol; 2011 Jul; 11(7):873-8. PubMed ID: 21238620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional plasticity of antigen-specific regulatory T cells in context of tumor.
    Addey C; White M; Dou L; Coe D; Dyson J; Chai JG
    J Immunol; 2011 Apr; 186(8):4557-64. PubMed ID: 21389255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development.
    Tran Thang NN; Derouazi M; Philippin G; Arcidiaco S; Di Berardino-Besson W; Masson F; Hoepner S; Riccadonna C; Burkhardt K; Guha A; Dietrich PY; Walker PR
    Cancer Res; 2010 Jun; 70(12):4829-39. PubMed ID: 20501837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
    Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
    Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
    Ugor E; Prenek L; Pap R; Berta G; Ernszt D; Najbauer J; Németh P; Boldizsár F; Berki T
    Immunobiology; 2018; 223(4-5):422-431. PubMed ID: 29223294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4
    Li Z; Liu X; Guo R; Wang P
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):1-9. PubMed ID: 27644153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ulinastatin on immune function of spleen in severely burned rats and its mechanism].
    Li J; Hu C; Yao Y; Yang H
    Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):266-71. PubMed ID: 27188484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X; Du Y; Huang Z
    Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.